Axinn Retains Top Rankings in LMG Life Sciences 2025
October 3, 2025
Axinn is pleased to announce that LMG Life Sciences has once again recognized the firm and its attorneys among the industry’s leaders for 2025. Partners Matt Becker and Aziz Burgy were named Life Sciences Stars, highlighting their continued excellence and impact in the field. Associate Ricardo Camposanto also retained his Rising Star designation, affirming his status as one of the industry’s emerging leaders.
This year, LMG Life Sciences ranked Axinn in Tier 2 for Hatch-Waxman Patent Litigation (Generic), underscoring the firm’s strength and experience in handling complex pharmaceutical patent cases.
LMG Life Sciences is the only legal ranking directory dedicated to identifying the top firms and lawyers across the life sciences sector.
About Axinn
Incisive. Inclusive. Invested. Inquisitive. We’re Axinn. Focusing on antitrust, intellectual property, and litigation, we make it our mission to understand your business so we can anticipate every move. Acting with precision and conviction, we protect and accelerate your business growth, always thinking ahead.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
Informa 34th Annual Advanced EU Brussels Conference
Speaking Engagement
Antitrust
Kisaco Research Pharma and Biotech Patent Litigation Summit 2025
Speaking Engagement
Intellectual Property
GCR Live: Women in Antitrust 2025
Speaking Engagement
Antitrust
Global Legal Group Global Class Actions Symposium 2025
Speaking Engagement
Litigation & Trials
ITCTLA Mock Hearing Program 2025
Speaking Engagement
Intellectual Property
ALM General Counsel Conference East 2025
Speaking Engagement
Antitrust
Axinn Recognized in Thirteen Categories of 2026 “Best Law Firms” Report
Awards & Recognitions
Antitrust
Mastering Multi-Jurisdictional Mergers: Strategies for Navigating Complex Global Antitrust Reviews
Byline Articles
Antitrust
The Government Shutdown’s Impact on Antitrust
Axinn Viewpoints
Antitrust
NAPABA Convention 2025
Sponsorship
Antitrust